Result of EGM

Oxford Biomedica PLC
01 February 2007

FOR IMMEDIATE RELEASE


1 February 2007


                 Oxford BioMedica Extraordinary General Meeting



Oxford, UK - 1 February 2007: Oxford BioMedica (LSE: OXB), a leading gene
therapy company, announced today that all resolutions proposed were duly passed
at the Extraordinary General Meeting held today in London.


                                     -Ends-


For further information, please contact:


Oxford BioMedica plc:                                 Tel: [phone]
Professor Alan Kingsman, Chief Executive


City/Financial Enquiries:                             Tel: [phone]
Lisa Baderoon/ Mark Court/ Mary-Jane Johnson
Buchanan Communications


Scientific/Trade Press Enquiries:                     Tel: [phone]
Katja Stout/ Gemma Bradley
Northbank Communications






                      This information is provided by RNS
            The company news service from the London Stock Exchange